Fig. 5From: Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticlesDeposition of mouse common complement components and inhibitors of the complement system on PNPs. The proteins adsorbed on PNPs were analyzed by LC-MS/MS (data presented as abundance values, arbitrary values generated by mass spec peak integration, n = 4) and Western blot (WB) analyses. LC-MS/MS data are shown as boxplot with median value. The deposition of common complement proteins (e.g., C3, C5, C6, C7, C8, C9) was quantified by LC-MS/MS analyses (A). To better evaluate complement activation, C3 fragmentation was studied by WB (B, C3α’: 63 kDa; C3α’2: 40 kDa). WB was also used to highlight the deposition of C9 (C, attended band at ~ 75 kDa), a terminal component of the complement activation. Complement inhibitors (D) were quantified by LC-MS/MS analysis. uPNPs: untargeted nanoparticles; tPNPs: targeted nanoparticles; MS: mouse serum; C1 inh: C1 inhibitor; C4BP: C4 binding proteins; empty: empty wellBack to article page